Chromosomes in Lymphomas and Solid Tumors

References

• Juneja S, Lukeis R, Tan L, et al. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: Non-random chromosomal abnormalities and histological correlations. Br J Haematol 1990; 76: 231–237
   PubMed Web of Science ®Google Scholar
• Offit K. Chromosome analysis in the management of patients with non-Hodgkin's lymphoma. Leuk Lymphoma 1992; 7: 275–282
   PubMed Web of Science ®Google Scholar
• Offit K, Wong G, Filippa D, et al. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 1991; 77: 1508–1515
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226: 1097–1099
   PubMed Web of Science ®Google Scholar
• Vandenberghe E, De Wolf-Peeters C, van den Oord J, et al. Translocation (11;14): A cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol 1991; 163: 13–18
   PubMed Web of Science ®Google Scholar
• Rimokh R, Berger F, Delsol G, et al. Rearrangement and overex-pression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993; 81: 3063–3067
   PubMed Web of Science ®Google Scholar
• Hirama T, Koeffler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995; 86: 841–854
   PubMed Web of Science ®Google Scholar
• Schuuring E, Verhoeven E, Mooi WJ, et al. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992; 7: 355–361
   PubMed Web of Science ®Google Scholar
• Jiang W, Zhang YJ, Kahn SM, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993; 90: 9026–9030
   PubMed Web of Science ®Google Scholar
• Nishida N, Fukuda Y, Komeda T, et al. Amplification and over-expression of the cyclin Dl gene in aggressive human hepatocellular carcinoma. Cancer Res 1994; 54: 3107–3110
   PubMed Web of Science ®Google Scholar
• Callender T, el-Naggar AK, Lee MS, et al. PRAD-1 (CCNDl)/cyclin Dl oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994; 74: 152–158
   PubMed Web of Science ®Google Scholar
• Bitter MA, Franklin WA, Larson RA, et al. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 1990; 14: 305–316
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Frizzera G, Edamura S, et al. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 1989; 73: 806–813
   PubMed Web of Science ®Google Scholar
• Shulman LN, Frisard B, Antin JH, et al. Primary Ki-1 anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 1993; 11: 937–942
   PubMed Web of Science ®Google Scholar
• Downing JR, Shurtleff SA, Zielenska M, et al. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 1995; 85: 3416–3422
   PubMed Web of Science ®Google Scholar
• Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284
   PubMed Web of Science ®Google Scholar
• Tilly H, Bastard C, Delastre T, et al. Cytogenetic studies in untreated Hodgkin's disease. Blood 1991; 77: 1298–1304
   PubMed Web of Science ®Google Scholar
• Döhner H, Bloomfield CD, Frizzera G, et al. Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosomes Cancer 1992; 5: 392–398
   PubMed Web of Science ®Google Scholar
• Weber-Matthiesen K, Deerberg J, Poetsch M, et al. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995; 86: 1461–1468
   Google Scholar
• Mitelman F. Catalog of Chromosome Aberrations in Cancer, 5th ed. Wiley-Liss, New York 1994
   Google Scholar
• Whang-Peng J, Triche TJ, Knutsen T, et al. Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 1984; 311: 584–585
   PubMed Web of Science ®Google Scholar
• Whang-Peng J, Triche TJ, Knutsen T, et al. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet 1987; 21: 185–208
   Web of Science ®Google Scholar
• Whang-Peng J, Freter CE, Knutsen T, et al. Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet 1987; 27: 155–157
   Google Scholar
• Zucman J, Delattre O, Desmaze C, et al. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepitheliomat (11; 22) translocation breakpoints. Genes Chromosomes Cancer 1992; 5: 271–277
   PubMed Web of Science ®Google Scholar
• May WA, Gishizsky ML, Lessnick SL, et al. Ewing sarcoma 11; 22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLU for transformation. Proc Natl Acad Sci USA 1993; 90: 5752–5756
   PubMed Web of Science ®Google Scholar
• Sorensen P HB, Lessnick SL, Lopez-Terrada D, et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genet 1994; 6: 146–151
   PubMed Web of Science ®Google Scholar
• Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet 1993; 4: 341–345
   PubMed Web of Science ®Google Scholar
• Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 1994; 54: 2837–2840
   PubMed Web of Science ®Google Scholar
• Douglass EC, Valentine M, Etcubanas E, et al. A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 1987; 45: 148–155
   PubMedGoogle Scholar
• Barr FG, Galili N, Holick J, et al. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet 1993; 3: 113–117
   PubMed Web of Science ®Google Scholar
• Shapiro DN, Sublett JE, Li B, et al. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 1993; 53: 5108–5112
   PubMed Web of Science ®Google Scholar
• Galili N, Davis RJ, Fredericks WJ, et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet 1993; 5: 230–235
   PubMed Web of Science ®Google Scholar
• Douglass EC, Shapiro DN, Valentine M, et al. Alveolar rhabdomyosarcoma with the t(2;13): Cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 1993; 21: 83–87
   PubMedGoogle Scholar
• Brodeur GM. Neuroblastoma: Clinical significance of genetic abnormalities. Cancer Surv 1992; 9: 673–688
   Google Scholar
• Mitani K, Kurosawa H, Suzuki A, et al. Amplification of N-myc in a rhabdomyosarcoma. Jpn J Cancer Res (Gann) 1986; 77: 1062–1065
   PubMedGoogle Scholar
• Lee WH, Murphree AL, Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 1984; 309: 458–60
   PubMed Web of Science ®Google Scholar
• Nau MM, Brooks BJ, Carney DN, et al. Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci USA 1986; 83: 1092–1096
   PubMed Web of Science ®Google Scholar
• Zafrani B, Gerbault-Seureau M, Mosseri V, et al. Cytogenetic study of breast cancer: Clinicopathologic significance of homogeneously staining regions in 84 patients. Hum Pathol 1992; 23: 542–547
   PubMed Web of Science ®Google Scholar
• Kallioniemi A, Kallioniemi O-P, Piper J, et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 1994; 91: 2156–2160
   PubMed Web of Science ®Google Scholar
• Theillet C, Adelaide J, Louason G, et al. FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer 1993; 7: 219–226
   PubMed Web of Science ®Google Scholar
• Berns EM, Klijn JG, van Putten WL, et al. c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 1992; 552: 1107–1113
   Google Scholar
• Karlseder J, Zeillinger R, Schneeberger C, et al. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 1994; 9: 42–48
   PubMed Web of Science ®Google Scholar
• Press MF, Pike MC, Chazin VR, et al. Her-2/neu expression in node-negative breast cancer: Direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res 1993; 53: 4960–4970
   PubMed Web of Science ®Google Scholar
• Wright C, Angus B, Nicholson S, et al. Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 1989; 49: 2087–2090
   PubMed Web of Science ®Google Scholar
• Borg Å, Baldetorp B, Ferno M, et al. c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int J Cancer 1992; 51: 687–691
   PubMed Web of Science ®Google Scholar
• Arps S, Rodewald A, Schmalenberger B, et al. Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 1993; 66: 93–99
   PubMed Web of Science ®Google Scholar
• Lundgren R, Mandahl N, Heim S, et al. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 1992; 4: 16–24
   PubMed Web of Science ®Google Scholar
• Micale MA, Mohamed A, Sakr W, et al. Cytogenetics of primary prostatic adenocarcinoma-Clonality and chromosome instability. Cancer Genet Cytogenet 1992; 61: 165–173
   PubMed Web of Science ®Google Scholar
• Johansson B, Heim S, Mandahl N, et al. Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer 1993; 6: 199–205
   PubMed Web of Science ®Google Scholar
• Casalone R, Portentoso P, Granata P, et al. Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma. Cancer Genet Cytogenet 1993; 68: 126–130
   PubMed Web of Science ®Google Scholar
• Aly MS, Dal Cin P, Van de Voorde W, et al. Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosomes Cancer 1994; 9: 227–233
   PubMed Web of Science ®Google Scholar
• Mitelman F, Kaneko Y, Trent J. Report of the committee on chromosome changes in neoplasia. Cytogenet Cell Genet 1990; 55: 358–386
   PubMedGoogle Scholar
• Macoska JA, Trybus TM, Sakr WA, et al. Fuorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 1994; 54: 3824–3830
   PubMed Web of Science ®Google Scholar
• Brothman AR, Patel AM, Peehl DM, et al. Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 1992; 62: 180–185
   PubMed Web of Science ®Google Scholar
• Brothman AR. Molecular cytogenetic analysis of human prostate cancer. Cancer Genet Cytogenet 1995; 84: 13, (abstract)
   Google Scholar
• Jenkins R, Takahashi S, Brown J, et al. Chromosomal alterations detected by fluorescence in situ hybridization (FISH) in prostate cancer. Sixth International Workshop on Chromosomes in Solid Tumors 13. 1995, abstract
   Google Scholar
• Visakorpi T, Hyytinen E, Koivisto P, et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 1995; 9: 401–406
   PubMed Web of Science ®Google Scholar
• Loehrer PJ, Williams SD, Einhorn LH. Testicular cancer: The quest continues. J Natl Cancer Inst 1988; 80: 1373–1382
   PubMed Web of Science ®Google Scholar
• de Jong B, Oosterhuis JW, Castedo S MMJ, et al. Pathogenesis of adult testicular germ cell tumors. A cytogenetic model. Cancer Genet Cytogenet 1990; 48: 143–167
   PubMed Web of Science ®Google Scholar
• Chaganti R SK, Rodriguez E, Bosl GJ. Cytogenetics of male germ cell tumors. Urol Clin North Am 1993; 20: 55–66
   PubMed Web of Science ®Google Scholar
• Smolarek TA, Blough Rl, Foster RS, et al. Identification of multiple chromosome 12 abnormalities in human testicular germ cell tumors by two-color fluorescence in situ hybridization (FISH). Genes Chromosomes Cancer 1995; 14: 252–258
   PubMed Web of Science ®Google Scholar
• Suijkerbuijk RF, Sinke RJ, Meloni AM, et al. Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet 1993; 70: 85–93
   PubMed Web of Science ®Google Scholar
• Smolarek TA. Cytogenetic and molecular cytogenetic analyses of untreated testicular germ cell tumors. Ph.D. thesis, Indiana University. 1995
   Google Scholar
• Samaniego F, Rodriguez E, Holdsworth J, et al. Cytogenetic and molecular analysis of human male germ cell tumors. Chromosome 12 abnormalities and gene amplification. Genes Chromosomes Cancer 1990; 1: 289–300
   PubMed Web of Science ®Google Scholar
• Zang KD. Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 1982; 6: 249–274
   PubMed Web of Science ®Google Scholar
• Mrozek K, Karakousis CP, Bloomfield CD. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q 13.3. Cancer Res 1993; 53: 1670–1675
   PubMed Web of Science ®Google Scholar
• Mandahl N, Heim S, Arheden K, et al. Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet 1988; 79: 203–208
   PubMed Web of Science ®Google Scholar
• Nilbert M, Heim S, Mandahl N, et al. Karyotypic rearrangements in 20 uterine leiomyomas. Cytogenet Cell Genet 1988; 49: 100–104
   Google Scholar
• Mark J, Sandros J, Wedell B, et al. Significance of the choice of tissue culture technique on the chromosomal patterns in human mixed salivary gland tumors. Cancer Genet Cytogenet 1988; 33: 229–244
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends in Genetics 1993; 9: 138–141
   PubMed Web of Science ®Google Scholar